首页> 外文期刊>Microbiology and Immunology >A simple screening method for detecting bindings between oligopeptides and HLA-DR molecules on filter papers: possible application for mapping of putative helper T-cell epitopes on MSP1 of Plasmodium falciparum.
【24h】

A simple screening method for detecting bindings between oligopeptides and HLA-DR molecules on filter papers: possible application for mapping of putative helper T-cell epitopes on MSP1 of Plasmodium falciparum.

机译:一种简单的筛选方法,可检测滤纸上的寡肽和HLA-DR分子之间的结合:恶性疟原虫MSP1上推定的辅助T细胞表位的可能应用。

获取原文
获取原文并翻译 | 示例
       

摘要

Binding capacities of synthetic peptides to HLA-DR molecules were tested on filter papers to identify putative helper T-cell epitopes on a malarial protein. The antigen tested was the merozoite surface glycoprotein 1 (MSP1) of Plasmodium falciparum, a vaccine candidate targeting the asexual erythrocytic stage. Bindings between synthetic oligopeptides and HLA-DR molecules were tested. Such bindings were not non-specific, and a known helper T-cell epitope peptide showed positive binding to the restricting HLA-DR molecule. By using this screening system, we observed the unequal distribution of HLA-DR-binding peptides in 10 out of 17 MSP1 blocks tested. Block #6 of MSP1 seemed to show the highest frequency in the positive binding; on the other hand, blocks #1 and #17, both of which were thought to be vaccine candidate regions, contained fewer HLA-DR binding peptides. This was not inconsistent with the results that block #17 was less stimulatory to peripheral T cells than block #6. The peptides with positive binding to HLA-DR showed actual epitope activities when we tested peptide-driven proliferation of human bulk T-cell lines, and association between the two parameters was statistically significant (P<0.001). For more detailed information for vaccine development, peptides with both IgG- and HLA-DR binding activities were mapped in block #17 of MSP1. Together with these results, we demonstrate that our simple screening system seems to provide essential information for vaccine development through uncovering locations of putative epitopes for human helper T cells.
机译:在滤纸上测试了合成肽与HLA-DR分子的结合能力,以鉴定疟疾蛋白上假定的辅助性T细胞表位。测试的抗原是恶性疟原虫的裂殖子表面糖蛋白1(MSP1),它是针对无性红细胞生成阶段的候选疫苗。测试了合成寡肽和HLA-DR分子之间的结合。这样的结合不是非特异性的,并且已知的辅助T细胞表位肽显示出与限制性HLA-DR分子的正结合。通过使用此筛选系统,我们在测试的17个MSP1区块中的10个中观察到了HLA-DR结合肽的不均等分布。 MSP1的第6嵌段似乎在阳性结合中显示出最高频率。另一方面,被认为都是疫苗候选区域的区块#1和#17含有较少的HLA-DR结合肽。这与第17块对周围T细胞的刺激性低于第6块的结果并不一致。当我们测试人大体积T细胞系的肽驱动的增殖时,与HLA-DR阳性结合的肽显示出实际的表位活性,并且这两个参数之间的关联具有统计学意义(P <0.001)。有关疫苗开发的更多详细信息,将具有IgG-和HLA-DR结合活性的肽定位在MSP1的17号区块中。结合这些结果,我们证明我们的简单筛选系统似乎通过揭示人类辅助T细胞的假定表位的位置,为疫苗开发提供了重要信息。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号